Native mass spectrometry combined with enzymatic dissection unravels glycoform heterogeneity of biopharmaceuticals
The specific glycosylation patterns of biological drugs often impact the efficacy and safety of the therapeutic product. Here the authors describe a native mass spectrometry approach that allows the resolution of highly complex glycosylation patterns on large proteins, which they apply to the therap...
Guardado en:
Autores principales: | Therese Wohlschlager, Kai Scheffler, Ines C. Forstenlehner, Wolfgang Skala, Stefan Senn, Eugen Damoc, Johann Holzmann, Christian G. Huber |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/652a3252f9884ca095fe82ff547d3b84 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dissecting ribosomal particles throughout the kingdoms of life using advanced hybrid mass spectrometry methods
por: Michiel van de Waterbeemd, et al.
Publicado: (2018) - Journal of biopharmaceutical statistics
- Biopharmaceutics & drug disposition
- Statistics in biopharmaceutical research
- European journal of pharmaceutics and biopharmaceutics